Johnson & Johnson Covid-19 Vaccine Distribution Delayed by U.S. Factory Mix-up, NYT Reports
01 April 2021 - 9:28AM
Dow Jones News
--A mix-up at a U.S. factory will delay distribution of the
Johnson & Johnson Covid-19 vaccine, the New York Times
reported.
--The NYT said that workers at the Baltimore plant had
accidentally conflated the vaccine's ingredients weeks ago and
ruined about 15 million doses of Johnson & Johnson's
vaccine.
--The plant is run by Emergent BioSolutions, a manufacturing
partner to Johnson & Johnson and AstraZeneca PLC, the NYT
said.
--Johnson & Johnson vaccine doses currently being delivered
and used nationwide were produced in the Netherlands and are not
affected, the NYT reported, adding that all further shipments of
the Johnson & Johnson vaccine were supposed to have come from
the Baltimore plant and are now in question while the quality
control issues are sorted out.
In after-hours trading, Johnson & Johnson shares were down
0.33% at $163.81, while Emergent Solutions' stock was down 4.85% at
$88.40.
Full story:
https://www.nytimes.com/live/2021/03/31/world/covid-19-coronavirus#johnson-and-johnson-vaccine-mixup
(END) Dow Jones Newswires
March 31, 2021 18:13 ET (22:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Aug 2023 to Aug 2024